ADAM17 and cancer: β integrins expressed on the surface of cells lacking ALCAM expression can mediate the binding and uptake of cancer-derived EVs lacking ALCAM through their interactions with specific EV ligands, such as the ADAM17 or fibronectin (Figure 8D).